-
EP4092024
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4092024
| EP4092024 - PYRIMIDINE-4(3H)-KETONE HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE AND PHARMACOLOGY [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 21.10.2022 Database last updated on 02.11.2024 | |
| Former | The international publication has been made Status updated on 23.07.2021 | Most recent event Tooltip | 17.08.2024 | Amendment by applicant | Applicant(s) | For all designated states Beijing InnoCare Pharma Tech Co., Ltd. Bldg.8, Community No.1, No.8 Courtyard Life Park Rd., ZGC Life Science Park Changping District, Beijing PRC Beijing 102206 / CN | [2022/47] | Inventor(s) | 01 /
CHEN, Xiangyang Bldg.8, No.8 Life Park Rd., ZGC Life Science Park Changping District Beijing 102206 / CN | 02 /
GAO, Yingxiang Bldg.8, No.8 Life Park Rd., ZGC Life Science Park Changping District Beijing 102206 / CN | [2022/47] | Representative(s) | Patentanwälte Magenbauer & Kollegen Partnerschaft mbB Plochinger Straße 109 73730 Esslingen / DE | [2022/47] | Application number, filing date | 21741216.2 | 13.01.2021 | [2022/47] | WO2021CN71375 | Priority number, date | CN20201056202 | 19.01.2020 Original published format: CN202010056202 | [2022/47] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021143701 | Date: | 22.07.2021 | Language: | ZH | [2021/29] | Type: | A1 Application with search report | No.: | EP4092024 | Date: | 23.11.2022 | Language: | EN | [2022/47] | Search report(s) | International search report - published on: | CN | 22.07.2021 | (Supplementary) European search report - dispatched on: | EP | 08.02.2024 | Classification | IPC: | C07D471/04, C07D471/10, C07D401/14, A61K31/506, A61P35/00, A61P43/00, A61P35/02, A61K45/06 | [2024/11] | CPC: |
C07D471/04 (EP,CN,KR,US);
A61K31/506 (EP,KR);
A61K31/513 (US);
A61K45/06 (EP,US);
A61P35/00 (EP,CN,KR);
A61P35/02 (EP,CN,KR);
A61P43/00 (EP,CN);
C07D401/14 (EP,CN,KR,US);
C07D491/107 (EP,CN,KR,US);
C07D519/00 (EP,CN,US)
(-)
| C-Set: |
A61K31/506, A61K2300/00 (EP)
|
| Former IPC [2022/47] | C07D471/04, C07D471/10, C07D401/14, A61K31/506, A61P35/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/47] | Title | German: | PYRIMIDIN-4(3H)-KETON HETEROZYKLISCHE VERBINDUNG, HERSTELLUNGSVERFAHREN DAFÜR UND VERWENDUNG DAVON IN MEDIZIN UND PHARMAKOLOGIE | [2022/47] | English: | PYRIMIDINE-4(3H)-KETONE HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE AND PHARMACOLOGY | [2022/47] | French: | COMPOSÉ HÉTÉROCYCLIQUE DE PYRIMIDINE-4(3H)-CÉTONE, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION EN MÉDECINE ET EN PHARMACOLOGIE | [2022/47] | Entry into regional phase | 09.08.2022 | Translation filed | 09.08.2022 | National basic fee paid | 09.08.2022 | Search fee paid | 09.08.2022 | Designation fee(s) paid | 09.08.2022 | Examination fee paid | Examination procedure | 09.08.2022 | Examination requested [2022/47] | 16.08.2024 | Amendment by applicant (claims and/or description) | 16.08.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 19.01.2023 | Renewal fee patent year 03 | 26.01.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XA]WO2016203405 (NOVARTIS AG [CH], et al) [X] 1-3,6-8 * pages 207, 216 and 217;; claims 1, 21, 22 *[A] 4,5 | International search | [Y]CN107787323 (NOVARTIS AG) [Y] 1-9 * description, embodiments 1-122, compound, and paragraphs [0016] and [0019] *; | [Y]WO2018130928 (NOVARTIS AG [CH], et al) [Y] 1-9* claim 1, and description, pages 36-43, table 1, compound *; | [Y]CN109311848 (JACOBIO PHARMACEUTICALS CO LTD) [Y] 1-9 * claims 1, 39 and 72-79, and description, embodiments 1-76, compound and paragraph [0211] * | by applicant | WO2015107495 | WO2016203405 | WO2017211303 | WO2018013597 | WO2018057884 | - RUESS DA et al., Nat. Med., (20180000), vol. 24, pages 954 - 960 | - LI J et al., Cancer Res, (20150000), vol. 75, pages 508 - 518 | - CHEN Y et al., Nature, (20160000), vol. 535, pages 148 - 52 |